Clinical Trials Browser

Has results × Hypersensitivity × Clear all

NCT06240741 2026-02-03

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Phase 3 Completed

71 enrolled 37 charts

Hypersensitivity

NCT04761822 2025-08-12

SARS

Phase 2 Completed

746 enrolled 28 charts

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

NCT02835625 2024-08-28

TOBE

Phase NA Completed

29,453 enrolled 15 charts

Breast Neoplasms, Hypersensitivity

NCT03406325 2020-04-09

Mast Cell Activation Test in Allergic Disease

19 enrolled 17 charts

Chronic Urticaria, Mast Cell Activation Syndrome, Anaphylaxis, Asthma, Eczema, Food Hypersensitivity, Hypersensitivity, Mastocytosis

NCT00928200 2019-02-19

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Phase 1 Terminated

1 enrolled 7 charts

LymphoidOther hematologic neoplasm

Hypersensitivity, Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01206777 2017-12-20

Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies

Phase 2 Completed

52 enrolled 4 charts

Hypersensitivity

NCT00929162 2012-08-07

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Phase 2 Terminated

120 enrolled 8 charts

Hypersensitivity, Neoplasms